Clinical Trials & Results
Search or filter the listing below to find a trial or results of a completed trial.
Showing 5 of 5 Results
All Results
No results found
Please change the filter settings to find the product(s) you are looking for. You can also use the search function to look up a product.
Efficacy and Safety of Reslizumab in Pediatric Patients With Eosinophilic Asthma
- Condition(s):
- Eosinophilic Asthma
- Status:
- Completed
- Requirements:
- 12 Years to 75 Years
- Interventions:
- Drug: Reslizumab | Drug: Placebo
Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma
- Condition(s):
- Eosinophilic Asthma
- Status:
- Completed
- Requirements:
- 18 Years to 65 Years
- Interventions:
- Drug: Reslizumab | Drug: Placebo
Evaluate the Efficacy and Safety of Reslizumab for Patients with Eosinophilic Asthma
- Condition(s):
- Eosinophilic Asthma
- Status:
- Completed
- Requirements:
- 12 Years to 75 Years
- Interventions:
- Drug: Reslizumab | Drug: Placebo
Evaluate the Safety and Efficacy of Reslizumab for Patients With Eosinophilic Asthma
- Condition(s):
- Eosinophilic Asthma
- Status:
- Terminated
- Requirements:
- 12 Years to 75 Years
- Interventions:
- Drug: Reslizumab
Study to Evaluate the Efficacy and Safety of Reslizumab in Patients With Eosinophilic Asthma
- Condition(s):
- Eosinophilic Asthma
- Status:
- Completed
- Requirements:
- 12 Years to 75 Years
- Interventions:
- Drug: Reslizumab | Drug: Placebo